Try our Advanced Search for more refined results

IN RE: PLAVIX PRODUCT LIABILITY AND MARKETING LITIGATION

  1. June 08, 2018

    Plavix MDL Judge Tosses 95 Cases Due To Inaction

    A New Jersey federal judge on Friday dismissed 95 cases from multidistrict litigation accusing Bristol-Myers Squibb and Sanofi-Aventis of falsely marketing the blood thinner Plavix because the patients in those cases never responded to court orders to retain new counsel or represent themselves after their attorneys withdrew.

  2. June 29, 2016

    Hawaii Escapes Plavix MDL Discovery Agreement

    Bristol-Myers Squibb Co. and Sanofi-Aventis U.S. LLC on Wednesday were denied a bid to hold Hawaii to a discovery coordination agreement in multidistrict litigation over allegedly misleading marketing of the blood thinner Plavix, according to New Jersey federal judge's order.

  3. June 13, 2016

    Hawaii Says It Can't Be Held To Plavix MDL Discovery Deal

    Hawaii urged a New Jersey federal court Monday not to hold it to a discovery coordination agreement in multidistrict litigation over allegedly misleading marketing of the blood thinner Plavix, saying Bristol-Meyers Squibb Co. and Sanofi-Aventis U.S. LLC can't force it to abide by a deal made in federal court because the state's claims were remanded.

  4. October 01, 2014

    BMS, Sanofi Lose Remand Challenge In Plavix MDL

    A New Jersey federal judge on Wednesday remanded 57 cases claiming injuries over the blood thinner Plavix despite arguments from Bristol-Meyers Squibb Co. and Sanofi-Aventis U.S. LLC that the suits fraudulently included drug distributor McKesson Corp. and unrelated plaintiffs to dodge federal jurisdiction.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!